SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2024-06-28 (portalportuario.cl)
Synthon chooses Kuehne+Nagel to expand its distribution services in Chile
By Editorial PortalPortuario @PortalPortuario Specialized storage and distribution services for health care products is what
Read more
2024-01-19 (thehindubusinessline.com)
Zydus Lifesciences subsidiary signs licensing agreement with Synthon BV
Zydus Worldwide DMCC partners with Synthon BV to manufacture and market Palbociclib tablets in the US.
Read more
2016-07-22 (vastgoedberichten.nl)
Synthon buys business complex in Nijmegen
Synthon purchases the business complex located on a corner location at Lagelandseweg 51-53-55 and Microweg 2 in Nijmegen. The property consists of 3,102 m² of commercial and office space on a plot of 4,608 m². Synthon is the largest Dutch independent pharmaceutical company.
Read more
2014-02-04 (vaktechnisch.nl)
Start new construction mAb Plant Synthon
Last week, pharmaceutical company Synthon gave the official go-ahead for the realization of a new factory on the Microweg in Nijmegen. In this so-called mAb plant, the company will produce therapeutic monoclonal antibodies.
Read more
2010-03-09 (outsourcing-pharma.com)
synthon continues latin america expansion with nafar buy
Synthon has completed the acquisition of Mexico-based Nafar Laboratories, adding to its presence in Latin America which includes recent purchases in Chile and Argentina.
Read more